In 2025, BioCentury, BayHelix and Insights Partner McKinsey & Company return to Singapore for the 4th East-West Biopharma Summit – a CEO and investor conference focused on Asia’s emerging Arc of Innovation. 

This year’s theme: How to Globalize Asia Innovation 
Asia biotechs must globalize to succeed. Many are seizing on the “Newco Model,” creating companies in the U.S. and Europe to house assets in partnership with Western investors. In parallel, Western biopharma companies and VCs are scouring Asia to fill pipelines. This means Asia’s Arc of Innovation is becoming a key engine for global biopharma. At the East-West Summit, biopharma executives and investors will debate the pros and cons of the Newco Model and how best to globalize Asia innovation.

Why Singapore?
As a gateway to Asia, Singapore is THE place to meet biotech decision-makers, investors, and pharma BD&L leaders from across the region, including Australia, China, Japan, India, South Korea, and Southeast Asia.

See for yourself
Join us for two-plus days of C-level networking, partnering and debate. 

This exclusive event is designed for VCs, CEOs, CFOs, CBOs and decision-makers from Asia and the West who are shaping the future of biopharma innovation. 

Register today
Early Bird Rates expire Dec. 31, 2024.